© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
It is said that 70% of men over 70 have prostate cancer. Does telomerase activation impact the incidence, severity, or recurrence?
I am passing along this request for funding from Jill Runion, my friend and the clinician who has cared for Porter since 2007. In this podcast, I discuss his amazing journey from spinal cord injury which can provide hope for many others.
After two years of TA-65 use, his median length is now 12,500 (from an estimated 9,400) with a very nice drop in critically-short telomeres to 4.5% (from a baseline of up to 20%). So if you believe what most research is showing regarding the connection between shorter telomeres and longevity, Mark has gained over 30 years of longevity in a time where he should have lost three years.
After a 2-yr hiatus, my Podcasts are returning with our 46th installment: Spinal Injury.
I will present a brief overview of Spinal Injury and then share a remarkable case of a man who is on the road to recovery after five years of complete paralysis.